Navigation Links
Braincells, Inc. Announces the Successful Completion of a Multiple Ascending Dose Study of BCI-838, a Group II mGluR2/3 Antagonist, and the Company's Plans for a Proof-of-Concept Study in Patients with Treatment-Resistant Depression
Date:12/5/2012

SAN DIEGO, Nov. 5, 2012 /PRNewswire/ -- BrainCells, Inc. (BCI), a leading biotechnology company developing novel compounds for the treatment of central nervous system (CNS) diseases, announced the successful completion of their Phase 1 multiple ascending dose (MAD) study of BCI-838, the oral prodrug for the company's Group II mGluR2/3 antagonist, BCI-632.  BCI will advance the clinical development program of the compound by initiating a Proof-of-Concept (PoC) study in patients with treatment-resistant depression (TRD) in early 2013.

The MAD study evaluated BCI-838 for safety, tolerability, pharmacokinetics and pharmacodynamic effect in healthy male and female subjects.  Three different dose levels of BCI-838 were administered orally once daily for 7 days.  The study's pharmacokinetic results indicate that all 3 doses of BCI-838 met or exceeded exposures of BCI-632 expected for the treatment of TRD.  BCI-838 showed a favorable safety profile with no treatment-related trends in clinical laboratory results, vital sign measurements, 12 lead ECG results, or physical examination findings.  In addition, the drug was well-tolerated within and up to the dose levels predicted for efficacy.  Adverse events (AEs), which were mild to moderate in intensity, were transient, and resolved without sequelae.  As a pharmacodynamic endpoint, quantitative electroencephalograms (qEEG) were included on day 1 and day 7 of the study.  At all 3 dose levels, significant changes in several frequency bands were observed at both time points indicative of the drug's brain penetration and engagement of its target.

"BCI-632's biological activity triggers changes in the brain through a mechanism similar to that for ketamine, an intravenous drug which has shown remarkable efficacy in treating patients with TRD.  Since ketamine is associated with a number of unwanted side effects such as short-term dissociation and psychosis, BCI-838 has th
'/>"/>

SOURCE BrainCells Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tria Beauty, Inc. Announces Partnership with Jenny McCarthy
2. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
3. UBM Canon Announces its New Medical Technology Seminar Series
4. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
5. Perrigo Company Announces The Appointment Of Industry Veteran To Executive Vice President And General Manager, Rx
6. Ultra Clean Announces Participation in the Midtown CAP Summit Investor Conference
7. MetaStat Announces Presentations at the 2012 San Antonio Breast Cancer Symposium
8. Young Innovations Announces Definitive Agreement to be Acquired by Linden Capital Partners
9. ObeTherapy Announces the Publication of Results Obtained with one of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes
10. GDS International Announces "Industry Leader of the Year" Award at its Fourth Annual European Pharmaceutical Drug Discovery Summit
11. Elbit Imaging Ltd. Announces InSightecs ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 ... 2015" therapeutic market research report of 68 pages ... online business intelligence library. The report ... on the therapeutic development for Pemphigus , ... assessment by drug target, mechanism of action (MoA), ...
(Date:3/31/2015)... KENNEBUNK, Maine , March 31, 2015 /PRNewswire/ ... aggregated enrollment in Medicare Advantage (MA) plans in ... approximately 17.3 million people were enrolled in Medicare ... of more than 1.3 million members year-over-year.  54.3 ... the Centers for Medicare and Medicaid Services (CMS), ...
(Date:3/31/2015)... , March 31, 2015  SynCardia Systems, Inc. has ... (IDE) clinical study on the effective use of its ... The FDA approval will ... as 30 heart failure patients. Patients enrolled in this ... as a bridge to a donor heart transplant. ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4
(Date:3/31/2015)... Azilen Technologies adds yet ... Product Development Company’ award at GESIA 2015. The firm ... 8th Annual Award GESIA 2015. This marks Azilen’s second ... category. It previously won the ‘Best Product Innovation’ award ... in product development, enterprise mobility solutions and open source ...
(Date:3/31/2015)... Nashville, TN (PRWEB) March 31, 2015 ... availability of Dragon® Medical Practice Edition 2, allowing them ... for medical practices with 24 physicians or less. Dragon ... time required to create quality patient records. , ... best technology solutions to our clients. Our goal has ...
(Date:3/31/2015)... 31, 2015 Horizon Blue Cross Blue ... its efforts to combat health insurance fraud resulted in ... of monies recovered and losses avoided -- in 2014. ... Horizon BCBSNJ created its fraud fighting, Special Investigations Unit ... efforts have saved members $261 million. , “Our ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Juvent Sports ... the 2015 PGA Merchandise show in Orlando. At the ... Tour player Maggie Will was interviewed and she shared ... been experiencing since she began integrating the Juvent Pro ... Juvent has been so instrumental to her chronic back ...
(Date:3/31/2015)... March 31, 2015 Over the last ... Shallow Water Blackout and conducted a survey to learn ... community. , For additional information about Shallow Water Blackout ... . To read the educational articles please go to ... yielded many useful comments and personal stories about people’s ...
Breaking Medicine News(10 mins):Health News:Azilen Technologies Receives ‘Best Product Development Company’ Award at GESIA 2015 2Health News:Medical Technology Solutions of America Announces Availability of Dragon® Medical Practice Edition 2 for Medical Professionals 2Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:Former LPGA Tour Winner Maggie Will Discovers The Juvent Micro-Impact Platform as a Pain Relief Breakthrough and Performance Enhancer 2Health News:Former LPGA Tour Winner Maggie Will Discovers The Juvent Micro-Impact Platform as a Pain Relief Breakthrough and Performance Enhancer 3
... Nursing Home, Assisted Living, Home Care and Adult Day Health ... April 30 The cost of long term ... putting significant financial pressure on those in or near retirement, ... the same time, the current economic downturn has led to ...
... to Nursing Home, Assisted Living, Home Care and Adult Day ... April 30 The cost of ... outpacing inflation, putting significant financial pressure on those in or ... At the same time, the current economic downturn has ...
... formulation, egg-based production system are biggest challenges, experts say , , ... a possible swine flu pandemic, U.S. health officials are already ... swine flu vaccine. , And even though experts say there,s ... to develop -- would work, many agree it,s the logical ...
... Nursing Home, Assisted Living, Home Care and Adult Day Health ... 30 The cost of long ... outpacing inflation, putting significant financial pressure on those in or ... At the same time, the current economic downturn has led ...
... Nebraskans Access to Nursing Home, Assisted Living, Home Care and ... StatewideRICHMOND, Va., April 30 The cost of long term ... putting significant financial pressure on those in or near retirement, ... the same time, the current economic downturn has led to ...
... April 30 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. ("China ... markets specialty pharmaceutical products in China, today,announced that ... Financial Officer,and has nominated Ms. Heung Mei Tsui ... Mr. Frank Waung brings to China ...
Cached Medicine News:Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Swine Flu Vaccine Still Months Away 2Health News:Swine Flu Vaccine Still Months Away 3Health News:Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 5Health News:Growth in Nebraska Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Nebraska Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Nebraska Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member 2Health News:China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member 3
... Evaluating pupil response and eye movement is ... exams. Thats because eye movements and pupil ... set of visual neuronal centers and pathways ... The VisPath Analyzer (VPA) provides pre-programmed visual ...
... has developed the DigiCat Imager ("DCI") to ... of cataracts. The DCI can measure the ... so an objective, appropriate and timely surgical ... that this technology is especially useful in ...
The new Riata® i lead family allows physicians even more versatility when managing patients with high defibrillation thresholds (DFTs)....
... BrainLAB combines ease of use ... to offer an image guided system ... the surgeons individual needs. With a ... base of more than 500 physicians, ...
Medicine Products: